tiprankstipranks
Iovance Biotherapeutics reports Q3 EPS (28c), consensus (30c)
PremiumThe FlyIovance Biotherapeutics reports Q3 EPS (28c), consensus (30c)
17d ago
Unusually active option classes on open November 5th
Premium
The Fly
Unusually active option classes on open November 5th
19d ago
IOVA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
IOVA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
20d ago
Iovance Biotherapeutics call volume above normal and directionally bullish
PremiumThe FlyIovance Biotherapeutics call volume above normal and directionally bullish
2M ago
Iovance Biotherapeutics call volume above normal and directionally bullish
Premium
The Fly
Iovance Biotherapeutics call volume above normal and directionally bullish
3M ago
Iovance Biotherapeutics put volume heavy and directionally bearish
Premium
The Fly
Iovance Biotherapeutics put volume heavy and directionally bearish
3M ago
Iovance Biotherapeutics reports Q2 EPS (34c), consensus (35c)
PremiumThe FlyIovance Biotherapeutics reports Q2 EPS (34c), consensus (35c)
4M ago
Iovance Biotherapeutics options imply 15.7% move in share price post-earnings
Premium
The Fly
Iovance Biotherapeutics options imply 15.7% move in share price post-earnings
4M ago
Iovance Biotherapeutics put volume heavy and directionally bearish
Premium
The Fly
Iovance Biotherapeutics put volume heavy and directionally bearish
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100